Engwegen JY - Search Results

1

Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.

Helgason HH, Engwegen JY, Zapatka M, Vincent A, Cats A, Boot H, Beijnen JH, Schellens JH. Helgason HH, et al. Among authors: engwegen jy. Oncol Rep. 2010 Jul;24(1):57-64. doi: 10.3892/or_00000828. Oncol Rep. 2010. PMID: 20514444

2

Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models.

Vermaat JS, van der Tweel I, Mehra N, Sleijfer S, Haanen JB, Roodhart JM, Engwegen JY, Korse CM, Langenberg MH, Kruit W, Groenewegen G, Giles RH, Schellens JH, Beijnen JH, Voest EE. Vermaat JS, et al. Among authors: engwegen jy. Ann Oncol. 2010 Jul;21(7):1472-1481. doi: 10.1093/annonc/mdp559. Epub 2009 Dec 18. Ann Oncol. 2010. PMID: 20022911 Free article.

3

Evaluation of human neutrophil peptide-1, -2 and -3 as serum markers for colorectal cancer.

van den Broek I, Sparidans RW, Engwegen JY, Cats A, Depla AC, Schellens JH, Beijnen JH. van den Broek I, et al. Among authors: engwegen jy. Cancer Biomark. 2010;7(2):109-15. doi: 10.3233/CBM-2010-0153. Cancer Biomark. 2010. PMID: 21178269

4

Serum degradome markers for the detection of breast cancer.

van Winden AW, van den Broek I, Gast MC, Engwegen JY, Sparidans RW, van Dulken EJ, Depla AC, Cats A, Schellens JH, Peeters PH, Beijnen JH, van Gils CH. van Winden AW, et al. Among authors: engwegen jy. J Proteome Res. 2010 Aug 6;9(8):3781-8. doi: 10.1021/pr100395s. J Proteome Res. 2010. PMID: 20557135

5

Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer.

Helgason HH, Engwegen JY, Zapatka M, Cats A, Boot H, Beijnen JH, Schellens JH. Helgason HH, et al. Among authors: engwegen jy. Oncol Lett. 2010 Mar;1(2):327-333. doi: 10.3892/ol_00000058. Epub 2010 Mar 1. Oncol Lett. 2010. PMID: 22966303 Free PMC article.

6

Identification of two new serum protein profiles for renal cell carcinoma.

Engwegen JY, Mehra N, Haanen JB, Schellens JH, Voest EE, Beijnen JH. Engwegen JY, et al. Oncol Rep. 2009 Aug;22(2):401-8. Oncol Rep. 2009. PMID: 19578783

7

Analysis of mass spectrometry data using sub-spectra.

Meuleman W, Engwegen JY, Gast MC, Wessels LF, Reinders MJ. Meuleman W, et al. Among authors: engwegen jy. BMC Bioinformatics. 2009 Jan 30;10 Suppl 1(Suppl 1):S51. doi: 10.1186/1471-2105-10-S1-S51. BMC Bioinformatics. 2009. PMID: 19208154 Free PMC article.

8

Influence of variations in sample handling on SELDI-TOF MS serum protein profiles for colorectal cancer.

Engwegen JY, Alberts M, Knol JC, Jimenez CR, Depla AC, Tuynman H, van Heukelem HA, Snel P, Smits ME, Cats A, Schellens JH, Beijnen JH. Engwegen JY, et al. Proteomics Clin Appl. 2008 Jun;2(6):936-45. doi: 10.1002/prca.200780068. Proteomics Clin Appl. 2008. PMID: 21136891 No abstract available.

9

Comparison of normalisation methods for surface-enhanced laser desorption and ionisation (SELDI) time-of-flight (TOF) mass spectrometry data.

Meuleman W, Engwegen JY, Gast MC, Beijnen JH, Reinders MJ, Wessels LF. Meuleman W, et al. Among authors: engwegen jy. BMC Bioinformatics. 2008 Feb 7;9:88. doi: 10.1186/1471-2105-9-88. BMC Bioinformatics. 2008. PMID: 18257918 Free PMC article.

10

Comparing the old and new generation SELDI-TOF MS: implications for serum protein profiling.

Gast MC, Engwegen JY, Schellens JH, Beijnen JH. Gast MC, et al. Among authors: engwegen jy. BMC Med Genomics. 2008 Jan 31;1:4. doi: 10.1186/1755-8794-1-4. BMC Med Genomics. 2008. PMID: 18237384 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page